| Year |
Citation |
Score |
| 2013 |
Wu J, Mukherjee A, Lebman DA, Fang X. Gene expression of the lysophosphatidic acid receptor 1 is a target of transforming growth factor beta Oncogene. 32: 3198-3206. PMID 22824789 DOI: 10.1038/Onc.2012.325 |
0.445 |
|
| 2013 |
Dcona MM, Mitra D, Goehe RW, Gewirtz DA, Lebman DA, Hartman MCT. Abstract 5665: New alternatives to photodynamic therapy based on light-enabled drug delivery. Cancer Research. 73: 5665-5665. DOI: 10.1158/1538-7445.Am2013-5665 |
0.304 |
|
| 2011 |
Wu J, Mukherjee A, Lebman DA, Fang X. Lysophosphatidic acid-induced p21Waf1 expression mediates the cytostatic response of breast and ovarian cancer cells to TGFβ. Molecular Cancer Research : McR. 9: 1562-70. PMID 21890597 DOI: 10.1158/1541-7786.Mcr-11-0340 |
0.38 |
|
| 2009 |
Coffman RL, Lebman DA, Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 1989. 170: 1039-1044. Journal of Immunology (Baltimore, Md. : 1950). 182: 8-13. PMID 19109127 |
0.332 |
|
| 2008 |
Miller AV, Alvarez SE, Spiegel S, Lebman DA. Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells. Molecular and Cellular Biology. 28: 4142-51. PMID 18426913 DOI: 10.1128/Mcb.01465-07 |
0.363 |
|
| 2008 |
Lebman DA, Spiegel S. Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling. Journal of Lipid Research. 49: 1388-94. PMID 18387885 DOI: 10.1194/Jlr.R800008-Jlr200 |
0.312 |
|
| 2005 |
Edmiston JS, Yeudall WA, Chung TD, Lebman DA. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells. Cancer Research. 65: 4782-8. PMID 15930298 DOI: 10.1158/0008-5472.Can-04-4354 |
0.729 |
|
| 2003 |
Kim AH, Lebman DA, Dietz CM, Snyder SR, Eley KW, Chung TD. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33. International Journal of Oncology. 23: 1593-9. PMID 14612931 |
0.413 |
|
| 2003 |
Kim AH, Lebman DA, Dietz CM, Snyder SR, Eley KW, Chung TD. Transforming growth factor-β is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33 International Journal of Oncology. 23: 1593-1599. DOI: 10.3892/Ijo.23.6.1593 |
0.504 |
|
| 2002 |
Lebman DA, Edmiston JS, Chung TD, Snyder SR. Heterogeneity in the transforming growth factor beta response of esophageal cancer cells. International Journal of Oncology. 20: 1241-6. PMID 12012005 |
0.733 |
|
| 2002 |
Lebman DA, Edmiston JS, Chung TD, Snyder SR. Heterogeneity in the transforming growth factor β response of esophageal cancer cells International Journal of Oncology. 20: 1241-1246. DOI: 10.3892/Ijo.20.6.1241 |
0.732 |
|
| 2001 |
Guilliano MJ, Foxx-Orenstein AE, Lebman DA. The microenvironment of human Peyer's patches inhibits the increase in CD38 expression associated with the germinal center reaction. Journal of Immunology (Baltimore, Md. : 1950). 166: 2179-85. PMID 11160270 DOI: 10.4049/Jimmunol.166.4.2179 |
0.623 |
|
| 2000 |
Coyle JH, Lebman DA. Correct immunoglobulin alpha mRNA processing depends on specific sequence in the C alpha 3-alpha M intron. Journal of Immunology (Baltimore, Md. : 1950). 164: 3659-65. PMID 10725723 DOI: 10.4049/Jimmunol.164.7.3659 |
0.747 |
|
| 1999 |
Lebman DA, Edmiston JS. The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes and Infection / Institut Pasteur. 1: 1297-304. PMID 10611758 DOI: 10.1016/S1286-4579(99)00254-3 |
0.746 |
|
| 1999 |
Lebman DA, Coyle JH. Developmental regulation of immunoglobulin mRNA processing and the IgA response: establishing a paradigm. Immunologic Research. 20: 43-53. PMID 10467982 DOI: 10.1007/Bf02786506 |
0.765 |
|
| 1998 |
Coyle JH, Borinstein SC, Woodward EO, Lebman DA. Predominant usage of the proximal poly(A) site in alpha mRNAs is not intrinsic to the 3' termini. International Immunology. 10: 669-78. PMID 9645615 DOI: 10.1093/Intimm/10.5.669 |
0.754 |
|
| 1997 |
Edmiston JS, Lebman DA. A transforming growth factor-beta regulable RNA-binding protein interacts specifically with germline Ig alpha transcripts. International Immunology. 9: 427-33. PMID 9088981 DOI: 10.1093/intimm/9.3.427 |
0.742 |
|
| 1994 |
Lebman DA, Park MJ, Hansen-bundy S, Pandya A. Mechanism for transforming growth factor β regulation of α mRNA in lipopolysaccharide-stimulated B cells International Immunology. 6: 113-119. PMID 8148320 DOI: 10.1093/Intimm/6.1.113 |
0.365 |
|
| 1988 |
Lebman DA, Fuhrman JA, Cebra JJ. Intraduodenal application of cholera holotoxin increases the potential of clones from Peyer's patch B cells of relevant and unrelated specificities to secrete IgG and IgA. Regional Immunology. 1: 32-40. PMID 3275128 |
0.372 |
|
| 1987 |
Lebman DA, Griffin PM, Cebra JJ. Relationship between expression of IgA by Peyer's patch cells and functional IgA memory cells. The Journal of Experimental Medicine. 166: 1405-18. PMID 3500260 |
0.406 |
|
| 1986 |
Cebra JJ, Cebra ER, Kotloff DB, Lebman DA, Schweitzer PA, Shahin RD. CH isotype switching in B cell differentiation. Biochemical Society Symposium. 51: 159-72. PMID 3493005 |
0.341 |
|
| 1981 |
Perussia B, Lebman D, Ip S, Rovera G, Trinchieri G. Terminal differentiation surface antigens of myelomonocytic cells are expressed in human promyelocytic leukemia cells (HL60) treated with chemical inducers Blood. 58: 836-843. DOI: 10.1182/blood.V58.4.836.bloodjournal584836 |
0.324 |
|
| 1981 |
Perussia B, Lebman D, Ip S, Rovera G, Trinchieri G. Terminal differentiation surface antigens of myelomonocytic cells are expressed in human promyelocytic leukemia cells (HL60) treated with chemical inducers Blood. 58: 836-843. DOI: 10.1182/blood.v58.4.836.836 |
0.324 |
|
| Show low-probability matches. |